Fluoxetine for maintenance of remission and to improve quality of life in patients with Crohn's disease: a pilot randomised placebo-controlled trial by Mikocka-Walus, A. et al.




Antonina Mikocka-Walus, Patrick A. Hughes, Peter Bampton, Andrea Gordon, Melissa A. Campaniello, 
Chris Mavrangelos, Benjamin J. Stewart, Adrian Esterman, Jane M. Andrews 
Fluoxetine for maintenance of remission and to improve quality of life in patients with Crohn's 
disease: a pilot randomised placebo-controlled trial 
Journal of Crohn's & colitis, 2017; 11(4):509-514 
© European Crohn’s and Colitis Organistion (ECCO) 2016. This is an Open Access article distributed 
under the terms of the Creative Commons Attribution Non-Commercial License 
(http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, 
distribution, and reproduction in any medium, provided the original work is properly cited. For 
commercial re-use, please contact journals.permissions@oup.com 
























31 July 2017 
 
